Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation

被引：0
|
作者：
Soret, Juliette
Cassinat, Bruno
Chevret, Sylvie
Dosquet, Christine
Giraudier, Stephane
Verger, Emmanuelle
Maslah, Nabih
Parquet, Nathalie
Chomienne, Christine
Kiladjian, Jean-Jacques
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3106.3106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3106
引用
收藏
页数：4
相关论文
共 50 条
  • [31] RECOMBINANT INTERFERON-ALPHA (IFN-ALPHA-B) THERAPY IN HAIRY-CELL LEUKEMIA
    SCHWARZMEIER, JD
    WAGNER, L
    PRISCHL, F
    SCHWABE, M
    LION, T
    MICKSCHE, M
    KOLLER, U
    BERNHART, M
    FRITZ, O
    SEEWANN, HL
    MICHLMAYR, G
    KLINISCHE WOCHENSCHRIFT, 1987, 65 (14): : 699 - 705
  • [32] INTERFERON-ALPHA THERAPY FOR PATIENTS WITH CHRONIC FATIGUE SYNDROME
    BROOK, MG
    BANNISTER, BA
    WEIR, WRC
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03): : 791 - 792
  • [33] RECOMBINANT INTERFERON-ALPHA THERAPY OF PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE DISORDERS WITH THROMBOCYTOSIS
    TALPAZ, M
    KURZROCK, R
    KANTARJIAN, H
    OBRIEN, S
    GUTTERMAN, JU
    AMERICAN JOURNAL OF MEDICINE, 1989, 86 (05): : 554 - 558
  • [34] Interferon-alpha as maintenance therapy in patients with multiple myeloma
    Yalcin, B
    Dogan, M
    Buyukcelik, A
    Doruk, H
    Tek, I
    Demirkazik, A
    ANNALS OF ONCOLOGY, 2005, 16 (12) : 1981 - 1981
  • [35] Results of the interferon-alpha 2b therapy in patients with Ph-negative chronic myeloproliferative disorder
    Sokolova, M. A.
    Khoroshko, N. D.
    Tsvetaeva, N. V.
    Sanatko, M. D.
    Misurin, A. V.
    Tihonova, V. V.
    BLOOD REVIEWS, 2007, 21 : S79 - S80
  • [36] THERAPY WITH INTERFERON (REC IFN-ALPHA-2C) IN MYELOPROLIFERATIVE DISORDERS AND THROMBOCYTOSIS
    LINKESCH, W
    GISSLINGER, H
    LUDWIG, H
    FLENER, R
    SINZINGER, H
    ACTA MEDICA AUSTRIACA, 1985, 12 (05) : 123 - 127
  • [37] Effect of therapy with interferon-alpha and pegylated interferon-alpha on platelet plug formation in patients with chronic hepatitis C
    Homoncik, M
    Jessner, W
    Sieghardt, W
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 145 - 145
  • [38] EFFECTIVE NATURAL INTERFERON-ALPHA THERAPY IN RECOMBINANT INTERFERON-ALPHA RESISTANT PATIENTS WITH HAIRY-CELL LEUKEMIA
    VONWUSSOW, P
    PRALLE, H
    HOCHKEPPEL, HK
    JAKSCHIES, D
    SONNEN, S
    SCHMIDT, H
    MULLERROSENAU, D
    FRANKE, M
    HAFERLACH, T
    ZWINGERS, T
    RAPP, U
    DEICHER, H
    BLOOD, 1991, 78 (01) : 38 - 43
  • [39] Long-term molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia
    Mauro, Endri
    BLOOD TRANSFUSION, 2012, 10 (04) : 559 - 559
  • [40] No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms - a Prospective Study
    Ocias, Lukas Frans
    Hansen, Dennis Lund
    Kristensen, Thomas Kielsgaard
    de Stricker, Karin
    El Fassi, Daniel
    Stentoft, Jesper
    Starklint, Jorn
    Frederiksen, Mikael
    Severinsen, Marianne Tang
    Bjerrum, Ole Weis
    Moller, Peter
    Mourits-Andersen, Torben
    Overgaard, Ulrik Malthe
    Hasselbalch, Hans Carl
    Bendtzen, Klaus
    Larsen, Thomas Stauffer
    BLOOD, 2015, 126 (23)
12345